A Safety and Pharmacokinetic Study of NBM-BMX Administered Orally to Asian Patients With Advanced Cancer
- First Posted Date
- 2019-01-18
- Last Posted Date
- 2023-08-15
- Lead Sponsor
- NatureWise Biotech & Medicals Corporation
- Target Recruit Count
- 21
- Registration Number
- NCT03808870
- Locations
- 🇨🇳
Taipei Veterans General Hospital, Taipei, Taiwan
🇨🇳National Cheng Kung University Hospital, Tainan, Taiwan
A Safety and Pharmacokinetic Study of NBM-BMX Administered Orally to Patients With Advanced Cancer
- First Posted Date
- 2018-10-31
- Last Posted Date
- 2022-04-13
- Lead Sponsor
- NatureWise Biotech & Medicals Corporation
- Target Recruit Count
- 33
- Registration Number
- NCT03726294
- Locations
- 🇺🇸
NEXT Oncology, San Antonio, Texas, United States
© Copyright 2025. All Rights Reserved by MedPath